Skip to Content

ProQuad Approval History

FDA Approved: Yes (First approved September 6, 2005)
Brand name: ProQuad
Generic name: measles, mumps, rubella and varicella virus vaccine, live
Dosage form: Injection
Company: Merck & Co., Inc.
Treatment for: Mumps Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Varicella-Zoster, Prophylaxis

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.

Development History and FDA Approval Process for ProQuad

DateArticle
Sep  6, 2005Approval Proquad Merck & Co., Inc. - Treatment for Measles, Mumps, Rubella and Varicella Vaccination
Nov  4, 2004Merck Files Biologics License Application for Proquad With U.S. Food and Drug Administration

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide